Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens

Urology

Volumn 61, Issue 5, 2003, Pages 1059-1062

  Trautner, Barbara W ^a,b   Hull, Richard A ^a   Darouiche, Rabih O ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ADHERENCE; BALLOON CATHETER; CANDIDA ALBICANS; CATHETER INFECTION; CONTROLLED STUDY; ESCHERICHIA COLI; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROVIDENCIA STUARTII; ULTRASOUND; URINE; URINE CATHETER;

EID: 0038639410     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(02)02555-4     Document Type: Article

References (28)

1. Darouiche R. Infections in patients with spinal cord injury. Mandell G., Bennett J., Dolin R. Principles and Practice of Infectious Disease. 2000;3159-3163 Churchill Livingstone, Philadelphia.
2. Darouiche R., Hull R. Bacterial interference for prevention of urinary tract infection an overview . J Spinal Cord Med. 23:2000;136-141.
3. Stamm W. Catheter-associated urinary tract infections epidemiology, pathogenesis, and prevention . Am J Med. 91:1991;65S-71S.
4. Warren J. Catheter-associated urinary tract infections. Infect Dis Clin North Am. 11:1997;609-622.
5. Warren J., Tenney J., Hoopes J., et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 146:1982;719-723.
6. Nicolle L., Bjornson J., Harding G., et al. Bacteriuria in elderly institutionalized men. N Engl J Med. 309:1983;1420-1425.
7. Nicolle L. Asymptomatic bacteriuria in the elderly. Infect Dis Clin North Am. 11:1997;647-662.
8. Tencer J. Asymptomatic bacteriuria - a long-term study. Scand J Urol Nephrol. 22:1988;31-34.
9. Hull R., Rudy D., Donovan W., et al. Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol. 163:2000;872-877.
10. Darouiche R., Donovan W., Del Terzo M., et al. Pilot trial of bacterial interference for preventing urinary tract infection. Urology. 58:2001;339-344.
11. Destedt J., Wollin T., Reid G. Biomaterials used in urology current issues of biocompatibility, infection, and encrustation . J Endourol. 12:1998;493-500.
12. Costerton J., Stewart P., Greenberg E. Bacterial biofilms a common cause of persistent infections . Science. 284:1999;1318-1322.
13. Trautner B., Darouiche R., Hull R., et al. Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. J Urol. 167:2002;375-379.
14. Warren J.W., Tenney J.H., Hoopes J.M., et al. A prospective microbiologic study of bacteriuria in patients with chronic indwelling urethral catheters. J Infect Dis. 146:1982;719-723.
15. Kauffman C., Vazquez J., Sobel J., et al. Prospective multicenter surveillance study of funguria in hospitalized patients. Clin Infect Dis. 30:2000;14-18.
16. Andersson P., Engberg I., Lidin-Janson G., et al. Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun. 59:1991;2915-2921.
17. Sherertz R., Raad I., Belani A., et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol. 28:1990;76-82.
18. Cardenas D., Hooten T. Urinary tract infection in persons with spinal cord injury. Arch Phys Med Rehabil. 76:1995;272-280.
19. Kunin C., Steele C. Culture of the surfaces of urinary catheters to sample urethral flora and study the effect of antimicrobial therapy. J Clin Microbiol. 21:1985;902-908.
20. Waites K., Canupp K., Brookings E., et al. Effect of oral ciprofloxacin on bacterial flora of perineum, urethra, and lower urinary tract in men with spinal cord injury. J Spinal Cord Med. 22:1999;192-198.
21. Reid G., Howard L. Effect of uropathogens of prophylaxis for urinary tract infection in spinal cord injured patients preliminary study . Spinal Cord. 35:1997;605-607.
22. Magnusson J., Schnurer J. Lactobacillus coryniformis subsp. coryniformis strain Si3 produces a broad-spectrum proteinaceous antifungal compound. Appl Environ Microbiol. 67:2001;1-5.
23. Bernet-Camard M., Lievin V., Brassart D., et al. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol. 63:1997;2747-2753.
24. Osset J., Bartolome R., Garcia E., et al. Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells. J Infect Dis. 183:2001;485-491.
25. Bruce A., Reid G. Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infections. Can J Microbiol. 34:1988;339-343.
26. Reid G., Bruce A., Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther. 14:1992;11-16.
27. Hagberg L., Bruce A., Reid G., et al. Colonization of the urinary tract with bacteria from the normal fecal and urethral flora in patients with recurrent urinary tract infection. Kass E., Svanborg-Eden C. Host Parasite Interactions in the Urinary Tract. 1989;194-197 University of Chicago Press, Chicago.
28. Watnick P., Kolter R. Biofilm, city of microbes. J Bacteriol. 182:2000;2675-2679.